Matthew Crowther, Beckman Coulter Diagnostics, on Emerging Resistance
In this video, Matthew Crowther, the Northern Europe Sales Manager at Beckman Coulter Diagnostics, discusses the topic of emerging resistance to antimicrobials. He begins by highlighting the growing concern over antibiotic resistance and its impact on public health worldwide.
Crowther highlights the urgency of addressing emerging resistance and emphasizes the crucial role that diagnostic technologies and collaborations play in combating this global health challenge. He emphasizes the importance of staying vigilant, adopting innovative approaches, and working together to preserve the effectiveness of antibiotics for future generations.
- Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
- Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
- Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
- Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
- Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more